Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context

Journal of Applied Toxicology

Volumn 29, Issue 4, 2009, Pages 275-288

  Hays, Sean M ^a   Aylward, Lesa L ^a  

^a LLP   (United States)

Author keywords

Biomonitoring; Biomonitoring equivalents; Pharmacokinetics; Risk assessment; Screening

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; ACRYLAMIDE; CADMIUM; TOLUENE;

BIOEQUIVALENCE; BIOLOGICAL MONITORING; CALCULATION; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FOLLOW UP; HEALTH HAZARD; HUMAN; INTERPERSONAL COMMUNICATION; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SCREENING; TARGET ORGAN; URINALYSIS;

ANIMALS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); ENVIRONMENTAL MONITORING; HUMANS; MODELS, STATISTICAL; PHARMACOKINETICS; PUBLIC HEALTH; RISK ASSESSMENT; UNITED STATES;

EID: 65649128629     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1410     Document Type: Review

References (67)

1. Alessio L, Apostoli P, Forni A, Toffoletto F. 1993. Biological monitoring of cadmium exposure - an Italian experience. Scand. J. Work Environ. Health 19: 27-33. (Pubitemid 24052132)
2. American Conference of Governmental Industrial Hygienists (ACGIH). 2001. Biological exposure index documentation for cadmium and inorganic substances, Cincinnati, OH. Available from: www.acgih.org.
3. Andersen ME. 1987. Tissue dosimetry in risk assessment, or what's the problem here anyway? Drinking Water Health 8: 8-23.
4. Andersen ME. 1995. What do we mean by . . . dose? Inhal. Toxicol. 7: 909-915.
5. Andersen ME, Clewell III H, Krishnan K. 1995. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal. 15: 533-537.
6. Aylward LL, Hays SM. 2008. Biomonitoring equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). Regul. Toxicol. Pharmacol. 51: S37-S48.
7. Aylward LL, Barton HA, Hays SM. 2008. Biomonitoring equivalents (BE) dossier for toluene (CAS No. 108-88-3). Regul. Toxicol. Pharmacol. 51: S27-S36.
8. Barlow S, Renwick AG, Kleiner J, Bridges JW, Busk L, Dybing E, Edler L, Eisenbrand G, Fink-Gremmels J, Knaap A, Kroes R, Liem D, Müller DJ, Page S, Rolland V, Schlatter J, Tritscher A, Tueting W, Würtzen G. 2006. Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem. Toxicol. 44: 1636-1650. (Pubitemid 44240404)
9. Barton HA, Pastoor TP, Baetcke K, Chambers JE, Diliberto J, Doerrer N, Driver JH, Hastings CE, Iyengar S, Krieger R, Stahl B, Timchalk C. 2006. The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments. Crit. Rev. Toxicol. 36: 9-35. (Pubitemid 43372195)
10. Beckett WS, Nordberg GF, Clarkson TW. 2007. Routes of exposure, dose, and metabolism of metals. In Handbook on the Toxicology of Metals, Nordberg GF, Fowler BA, Nordberg M, Friberg LT (eds). Elsevier: Amsterdam; 39.
11. Benignus VA, Boyes WK, Kenyon EM, Bushnell PJ. 2007. Quantitative comparisons of the acute neurotoxicity of toluene in rats and humans. Toxicol. Sci. 100: 146-155. (Pubitemid 47617812)
12. Bergmark E, Calleman CJ, Costa LG. 1991. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol 111: 352-363.
13. Bradberry SM, Watt BE, Proudfoot AT, Vale JA. 2000. Mechanisms of toxicity, clinical features, and management of acute chlorophenoxy herbicide poisoning: a review. J. Toxicol. Clin. Toxicol. 38: 111-122. (Pubitemid 30212832)
14. Bushnell PJ, Oshiro WM, Samsam TE, Benignus VA, Krantz QT, Kenyon EM. 2007. A dosimetric analysis of the acute behavioral effects of inhaled toluene in rats. Toxicol. Sci. 99: 181-189. (Pubitemid 47250378)
15. Centers for Disease Control and Prevention. 2005. Third National Report on Human Exposure to Environmental Chemicals. NCEH publication no. 05-0570. Atlanta, GA: National Center for Environmental Health, Division of Laboratory Sciences
16. Choudhury H, Harvey T, Thayer WC, Lockwood TF. 2001. Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure-biokinetics model. J. Toxicol. Environ. Health, Pt A 63: 321-350. (Pubitemid 32643361)
17. Clewell HJ, Tan YM, Campbell JL, Andersen ME. 2008. Quantitative interpretation of human biomonitoring data. Toxicol. Appl. Pharmacol. 231(1): 122-133.
18. Doerge DR, Young JF, McDaniel LP, Twaddle NC, Churchwell MI. 2005a. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol. Appl. Pharmacol. 208: 199-209. (Pubitemid 41457223)
19. Doerge DR, Gamboa de Costa G, McDaniel LP, Churchwell MI, Twaddle NC, Beland FA. 2005b. DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat. Res. 580: 131-141.
20. Dorne JL, Renwick AG. 2005. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 85: 20-26. (Pubitemid 41511345)
21. Fennell TR, Sumner SC, Snyder RW, Burgess J, Spicer R, Bridson WE, Friedman MA. 2005. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci. 85: 447-459. (Pubitemid 40614275)
22. Fiserova-Bergerova V. 1987. Development of biological exposure indices (BEIs) and their implementation. Appl. Ind. Hyg. 2: 87-92.
23. Fiserova-Bergerova V. 1990. Application of toxicokinetic models to establish biological exposure indicators. Ann. Occup. Hyg. 34: 639-651.
24. Georgopoulos PG, Sasso AF, Isukapalli SS, Lioy PJ, Vallero DA, Okino M, Reiter L. 2009. Reconstructing population exposures to environmental chemicals from biomarkers: Challenges and opportunities. J. Exp. Sci. Environ. Epidemiol. (in press).
25. Ghanayem BI, McDaniel LP, Churchwell MI, Twaddle NC, Snyder R, Fennell TR, Doerge DR. 2005. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 88: 311-318. (Pubitemid 41672140)
26. Hays SM, Aylward LL. 2008. Biomonitoring equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1). Regul. Toxicol. Pharmacol. 51: S57-S67.
27. Hays SM, Becker RA, Leung HW, Aylward LL, Pyatt DW. 2007. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 47: 96-109.
28. Hays SM, Aylward LL, LaKind JS. 2008a. Introduction to the Biomonitoring Equivalents Pilot Project: development of guidelines for the derivation and communication of Biomonitoring Equivalents. Regul. Toxicol. Pharmacol. 51: S1-S2.
29. Hays SM, Aylward LL, LaKind JS, Bartels MJ, Barton HA, Boogaard PJ, Brunk C, DiZio S, Dourson M, Goldstein DA, Kilpatrick ME, Krewski D, Krishnan K, Lipscomb J, Nordberg M, Okino M, Tan Y-M, Viau C, Yager JW. 2008b. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents expert workshop. Regul. Toxicol. Pharmacol. 51: S4-S15.
30. Hays SM, Nordberg M, Yager JW, Aylward LL. 2008c. Biomonitoring equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9). Regul. Toxicol. Pharmacol. 51: S49-S56.
31. Health Canada. 1992. Canadian Environmental Protection Act. Priority Substances List Assessment Report No. 4. Toluene. Government of Canada. Canadian Communications Group, Ottawa.
32. International Programme on Chemical Safety. 1992. Environmental Health Criteria 134. Cadmium. World Health Organization: Geneva.
33. Jang J-Y. 1996. Simulation of the toluene in venous blood with a physiologically based pharmacokinetic model: its application to Biological Exposure Index development. Appl. Occup. Environ. Hyg. 11: 1092-1095. (Pubitemid 26299511)
34. Joint WHO/FAO Expert Committee on Food Additives. 2001. Evaluation of Certain Food Additives and Contaminants. Fifty-fifth Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 901. World Health Organization: Geneva.
35. Kjellström T, Nordberg GF. 1978. A kinetic model of cadmium metabolism in the human being. Environ. Res. 16: 248-269. (Pubitemid 8369435)
36. Knopp D. 1994. Assessment of exposure to 2,4-dichlorophenoxyacetic acid in the chemical industry: results of a five year biological monitoring study. Occup Environ Med 51: 152-159. (Pubitemid 24106161)
37. Knopp D, Glass S. 1991. Biological monitoring of 2,4- dichlorophenoxyacetic acid-exposed workers in agriculture and forestry. Int. Arch. Occup. Environ. Health 63: 329-333.
38. Kohli JD, Khanna RN, Gupta BN, Dhar MM, Tandon JS, Sircar KP. 1974. Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica 4: 97-100.
39. Kroes R, Galli C, Munro I, Schilter B, Tran L, Walker R, Würtzen G. 2000. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem. Toxicol. 38: 255-312. (Pubitemid 30137253)
40. LaKind JS, Aylward LL, Brunk C, DiZio S, Dourson M, Goldstein DA, Kilpatrick ME, Krewski D, Bartels MJ, Barton HA, Boogaard PJ, Lipscomb J, Krishnan K, Nordberg M, Okino M, Tan Y-M, Viau C, Yager JW, Hays SM. 2008. Guidelines for the communication of biomonitoring equivalents: report from the Biomonitoring Equivalents expert workshop. Regul. Toxicol. Pharmacol. 51: S16-S26.
41. Lauwerys RR, Hoet P. 2001. Industrial Chemical Exposure. Guidelines for Biological Monitoring, 3rd edn. Lewis: New York.
42. Liao KH, Tan Y-M, Clewell HJ. 2007. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds (VOCs). Risk Anal. 27(5): 1223-1236.
43. Mage DT, Allen RH, Gondy G, Smith W, Barr DB, Needham LL. 2004. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J. Exp. Anal. Environ. Epidemiol. 14: 457-465. (Pubitemid 40023187)
44. Needham LL, Gerthoux PM, Patterson DG Jr, Brambilla P, Smith SJ, Sampson EJ, Mocarelli P. 1999. Exposure assessment: serum levels of TCDD in Seveso, Italy. Environ. Res. 80: S200-S206. (Pubitemid 29143246)
45. Nong A, McCarver DG, Hines RN, Krishnan K. 2006. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. Toxicol. Appl. Pharmacol. 214: 78-87. (Pubitemid 43867671)
46. Nordberg GF, Nogawa K, Nordberg M, Friberg, LT. 2007. Cadmium. In Handbook on the Toxicology of Metals, Nordberg GF, Fowler BA, Nordberg M, Friberg L (eds). Academic Press: Burlington, MA; 446-486.
47. National Research Council. 2006. Human Biomonitoring for Environmental Chemicals. Committee on Human Biomonitoring for Environmental Toxicants. The National Academy Press: Washington, DC.
48. Orlowski C, Piotrowski JK, Subdys JK, Gross A. 1998. Urinary cadmium as indicator of renal cadmium in humans: an autopsy study. Hum. Exp. Toxicol. 17: 302-306. (Pubitemid 28342337)
49. Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällstrom I. 1976. Evaluation of genetic risks of alkylating agents. II. Hemoglobin as a dose monitor. Mutat. Res. 34: 1-10.
50. Perucca J, Bouby N, Valeix P, Bankir L. 2007. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R700-705. (Pubitemid 46207719)
51. Pierce CH, Dills RL, Morgan MS, Nothstein GL, Shen DD, Kalman DA. 1996. Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model. Toxicol. Appl. Pharmacol. 139: 49-61. (Pubitemid 26247061)
52. Rigas ML, Okino MS, Quackenboss JJ. 2001. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. Toxicol. Sci. 61: 374-381. (Pubitemid 32499403)
53. Saghir SA, Mendrala AL, Bartels MJ, Day SJ, Hansen SC, Sushynski JM, Bus JS. 2006. Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. Toxicol. Appl. Pharmacol. 211: 245-260.
54. Satarug S, Baker JR, Reilly PE, Moore MR, Williams DJ. 2002. Cadmium levels in the lung, liver, kidney cortex, and urine samples from Australians without occupational exposure to metals. Arch. Environ. Health 57: 69-77. (Pubitemid 34627755)
55. Sauerhoff MW, Braun WH, Blau GE, Gehring PJ. 1977. The fate of 2,4-dichlorophenoxyacetic acid (2,4-D) following oral administration to man. Toxicology 8: 3-11. (Pubitemid 8153868)
56. Sexton K, Adgate JL, Church TR, Ashley DL, Needham LL, Ramachandran G, Fredrickson AL, Ryan AD. 2005. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ. Health Perspect. 113: 342-349. (Pubitemid 40450669)
57. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, Macdonald N, Clewell H, Allen B, Van Landingham C. 2006. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit. Rev. Toxicol. 36: 481-608. (Pubitemid 44396721)
58. Tan YM, Liao KH, Clewell HJ, 3rd. 2007. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J. Exp. Sci. Environ. Epidemiol. 17: 591-603.
59. Tardif R, Lapare S, Krishnan K, Brodeur J. 1993. Physiologically based modeling of the toxicokinetic interaction between toluene and mxylene in the rat. Toxicol. Appl. Pharmacol. 120: 266-273. (Pubitemid 23203331)
60. Tardif R, Lapare S, Charest-Tardif G, Brodeur J, Krishnan K. 1995. Physiologically based modeling of a mixture of toluene and xylene in humans. Risk Anal. 15: 335-342.
61. Tareke E, Twaddle NC, McDaniel LP, Churchwell MI, Young JF, Doerge DR. 2006. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Toxicol. Appl. Pharmacol. 217: 63-75. (Pubitemid 44635662)
62. Timchalk C. 2004. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. Toxicology 200: 1-19. (Pubitemid 38680682)
63. United States Environmental Protection Agency. 2004. Memorandum: 2,4-D-Second Report of the Hazard Identification Assessment Review Committee. TXR-0052303: Office of Prevention, Pesticides, and Toxic Substances.
64. United States Environmental Protection Agency. 2007a. Acrylamide. Integrated Risk Information System (IRIS) record. Available from: http://toxnet.nlm.nih.gov/ (accessed 30 November 2007).
65. United States Environmental Protection Agency. 2007b. Toxicological review of 1,1,1-trichloroethane (CAS No. 71.55-6) in support of summary information on the Integrated Risk Information System (IRIS). EPA/635/R-03/013. Washington, DC.
66. van Asperen J, Rijcken WR, Lammers JH. 2003. Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats. Toxicol. Lett. 138: 51-62. (Pubitemid 36139965)
67. van Ravenzwaay B, Hardwick TD, Needham D, Pethen S, Lappin GJ. 2003. Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog. Xenobiotica 33: 805-821. (Pubitemid 37129905)